Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Customising Cancer Treatment - The Challenge Of Genetics

22.12.2004


At the Norwegian Radium Hospital in Oslo, scientists are approaching methods that will improve the patients’ chances of survival and reduce unnecessary treatment.

The cancer treatment of today involves a lot of trial and error. Cancer cells that have started to grow uncontrollably, must be stopped. We use different kinds of medicinal drugs to stop cell growth and induce apoptosis, i.e. make the cells commit suicide. However, nobody knows whether or not the chosen form of medication has an effect on the patient until it has been tried out over a period of time. There is always a risk of losing time, especially if the tumour is big and has to be treated with medication before it is possible to perform surgery.

The problem with cancer treatment today is that it does not consider the genetic variety of human beings and the fact that each individual tumour is genetically unique.



"By giving the same medication to all patients that have the same diagnosis, there is a risk that some may die in the course of the disease because the drug is not working, while others may be poisoned by excessive doses. Although most patients will recover, it is not easy to predict who will recover and who will not," says Vessela Nedelcheva Kristensen.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

By conducting meticulous research and with the help of the latest, state-of-the-art instrument called Nanochip Workstation, Nedelcheva Kristensen and her research team are trying to identify the genes that have an influence on how anti-cancer drugs work on each patient. With grants from the Research Council of Norway’s National Programme for Research in Functional Genomics, FUGE, this young scientist takes part in research that may revolutionise cancer treatment. The researchers take samples from each tumour and analyse them, and they take blood samples from the patients to analyse their genetic sensitivity to an anti-cancer drug. This sensitivity varies according to each individual.

"By genetically testing each tumour, we may be able to say which form of treatment suits each patient. This is groundwork for individually tailored cancer treatment," she says.

Thomas Evensen | alfa
Further information:
http://www.forskningsradet.no/forport/application?lang=en_UK

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>